Healthy Skepticism Library
Items published in 2011
There are 502 items in the Healthy Skepticism Library that were published in 2011.
Page 5 of 6 pages ‹ First < 3 4 5 6 >
HSL19019
Bayer, Baxter pay multimillion indemnity to haemophiliacs
Coalition against Bayer Dangers (Germany) 2011 Jan 24
HSL19016
Nagarajan R
MNC in secret pact with universities for food education
The Times of India 2011 Jan 24
http://timesofindia.indiatimes.com/india/MNC-in-secret-pact-with-universities-for-food-education/articleshow/7350233.cms
HSL19059
Kanamori Y, Malone RE
Conveying misinformation: Top-ranked Japanese books on tobacco
Tobacco Induced Diseases 2011 Jan 24; 9:3
http://www.tobaccoinduceddiseases.com/content/9/1/3/abstract
HSL19081
Sanchís I
Las medicinas curan o causan cualquier enfermedad
Lavanguardia 2011 Jan 24
http://www.lavanguardia.es/lacontra/20110124/54105214595/las-medicinas-curan-o-causan-cualquier-enfermedad.html
HSL19188
Pfizer fined over Lipitor ads
Pharmacy Daily 2011 Jan 24
pharmacydaily.com.au
HSL19256
Silverman E
Should A Paxil Journal Article Be Retracted?
Pharmalot 2011 Jan 24
http://www.pharmalot.com/2011/01/should-a-paxil-journal-article-be-retracted/
HSL19216
Zajac A
Blowing the whistle on drug firms
The LA Times 2011 Jan 24
http://www.latimes.com/news/nationworld/nation/la-na-whistle-blower-20110124,0,5954723.story
HSL19017
Harris G
Federal Research Center Will Help Develop Medicines
The New York Times 2011 Jan 23
http://www.nytimes.com/2011/01/23/health/policy/23drug.html?_r=1
HSL19134
Mackert M, Love B, Holton AE
Journalism as Health Education: Media Coverage of a Nonbranded Pharma Web Site
Telemed J E Health 2011 Jan 23;
http://www.liebertonline.com/doi/abs/10.1089/tmj.2010.0127
HSL19218
Shaywitz D, Mammen M
The next killer app
The Boston Globe 2011 Jan 23
http://www.boston.com/bostonglobe/editorial_opinion/oped/articles/2011/01/23/the_next_killer_app/
HSL19015
France's Mediator° scandal: take the high road
Prescrire Int. 2011 Jan 21;
http://english.prescrire.org/en/81/168/46752/0/NewsDetails.aspx
HSL19171
Jack A
GSK’s US sales tactics undergo radical change
The Finanical Times 2011 Jan 21
http://www.ft.com/cms/s/0/42cc3cc8-2594-11e0-8258-00144feab49a.html#ixzz1EY16ss00
HSL19172
Edwards J
The iPad: Now Poised to Steal Drug Sales Reps’ Jobs
BNet 2011 Jan 20
http://www.bnet.com/blog/drug-business/the-ipad-now-poised-to-steal-drug-sales-reps-8217-jobs/7122
HSL19192
Taylor L
30% cut in Hungary's drug spending next month?
Pharma Times 2011 Jan 19
http://www.pharmatimes.com/Article/11-01-19/30_cut_in_Hungary_s_drug_spending_next_month.aspx
HSL19229
Kopp C
Say no to seeing sales reps
BMJ 2011 Jan 19; 342:
http://www.bmj.com/content/342/bmj.d132.extract
HSL19143
Hassner Sharav V
Stop Retaliating Against Whistleblowers
Alliance for Human Research Protection 2011 Jan 19
http://www.ahrp.org/cms/content/view/754/9/
HSL19146
Chimonas S, Patterson L, Raveis VH, Rothman DJ
Managing Conflicts of Interest in Clinical Care: A National Survey of Policies at U.S. Medical Schools
Acad Med 2011 Jan 18;
http://journals.lww.com/academicmedicine/Abstract/publishahead/Managing_Conflicts_of_Interest_in_Clinical_Care__A.99895.aspx
HSL19174
White A, Bodoni S
Bayer Among Drug Firms in EU Probe of Patent Deals
Bloomberg Businessweek 2011 Jan 17
http://www.businessweek.com/news/2011-01-17/bayer-among-drug-firms-in-eu-probe-of-patent-deals.html
HSL19259
Silverman E
What 20 Years Of Pharma Fraud Has Wrought
Pharmalot 2011 Jan 17
http://www.pharmalot.com/2010/12/what-20-years-of-pharma-fraud-has-wrought/
HSL19262
Ramos J
Spotlight on Industry Ties of Health Advocacy Groups
Health Watch 2011 Jan 17
http://healthwatched.org/
HSL19013
Chazan D
France pledges reform after diabetes drug scandal
BBC News 2011 Jan 15
http://www.bbc.co.uk/news/world-europe-12200506
HSL19274
Unintended direct conflict between pharmaceutical marketing and public health
The Medical News 2011 Jan 14
http://www.news-medical.net/news/20110114/Unintended-direct-conflict-between-pharmaceutical-marketing-and-public-health.aspx
HSL19069
Dickinson JG
Life sciences waiting on social media rules
Medical Marketing & Media 2011 Jan 14
http://www.mmm-online.com/life-sciences-waiting-on-social-media-rules/article/194954/
HSL19149
Rothman SM, Raveis VH, Friedman A, Rothman DJ
Health Advocacy Organizations and the Pharmaceutical Industry: An Analysis of Disclosure Practices
Am J Public Health 2011 Jan 13;
http://ajph.aphapublications.org/cgi/content/short/AJPH.2010.300027v1
HSL19219
Wilson D
Study Finds Lack of Disclosure Among Advocacy Groups
The New York Times 2011 Jan 13
http://prescriptions.blogs.nytimes.com/2011/01/13/study-finds-lack-of-disclosure-among-advocacy-groups/
HSL19257
Silverman E
Should Health Advocacy Groups Disclose Funding?
Pharmalot 2011 Jan 13
http://www.pharmalot.com/2011/01/should-health-advocacy-groups-disclose-funding/
HSL19263
Wang M
Health Advocacy Groups Take Drug Company Cash—Often Without Full Disclosures, Report Says
ProPublica 2011 Jan 13
http://www.propublica.org/blog/item/health-advocacy-groups-take-drug-company-cashoften-without-full-disclosures
HSL19148
Brody H, Light DW
The Inverse Benefit Law: How Drug Marketing Undermines Patient Safety and Public Health.
Am J Public Health 2011 Jan 13;
http://ajph.aphapublications.org/cgi/content/short/AJPH.2010.199844v1
HSL19011
Tinari S, Häner H, Padrutt R
The Tamiflu Saga – A pandemic business
Falo and Rundschau : RSI and SF 1 2011 Jan 120
HSL19220
Taylor L
Drugmakers sue Czech govt over pricing, insurance moves
Pharma Times 2011 Jan 12
http://www.pharmatimes.com/Article/11-01-12/Drugmakers_sue_Czech_govt_over_pricing_insurance_moves.aspx
HSL19233
Chan A
Access to clinical trial data
BMJ 2011 Jan 12; 342:
http://www.bmj.com/content/342/bmj.d80.extract
HSL19232
Jefferson T, Doshi P, Thompson M, Heneghan C
Ensuring safe and effective drugs: who can do what it takes?
BMJ 2011 Jan 11; 342:
http://www.bmj.com/content/342/bmj.c7258.extract
HSL19234
Benkimoun P
French drug journal is sued for criticising Protopic’s licence extension
BMJ 2011 Jan 11; 342:
http://www.bmj.com/content/342/bmj.d158.extract
HSL19283
Reddy KS, Patel V, Jha P, Paul VK, Kumar AS, Dandona L; for The Lancet India Group for Universal Healthcare.
Towards achievement of universal health care in India by 2020: a call to action.
Lancet 2011 Jan 11;
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736%2810%2961960-5
HSL19010
Jessop N
Will DTC Advertising Appear In Europe?
PharmTech 2011 Jan 7
http://pharmtech.findpharma.com/pharmtech/article/articleDetail.jsp?id=702161&sk=a4ba12396a7bcfa6e9f9b30a20534376
HSL19221
Kendall B
Court Takes Up Drug-Data Case
The Wall Street Journal 2011 Jan 7
http://online.wsj.com/article/SB10001424052748704055204576068260177082914.html
HSL19231
Smyth RMD, Kirkham JJ, Jacoby A, Altman DG, Gamble C, Williamson PR
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists
BMJ 2011 Jan 6; 342:
http://www.bmj.com/content/342/bmj.c7153.abstract
HSL19235
Moynihan R
Beware the fortune tellers peddling genetic tests
BMJ 2011 Jan 6; 342:
http://www.bmj.com/content/342/bmj.c7233.extract
HSL19150
Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS
Increasing off-label use of antipsychotic medications in the United States, 1995-2008
Pharmacoepidemiol Drug Saf 2011 Jan 6;
http://onlinelibrary.wiley.com/doi/10.1002/pds.2082/abstract
HSL19258
Silverman E
When Reps Are Told To Sell ‘Gobs Of Dope’
Pharmalot 2011 Jan 5
http://www.pharmalot.com/2011/01/when-reps-are-told-to-sell-gobs-of-dope/
HSL19138
Un laboratoire attaque Prescrire
Le Figaro 2011 Jan 4
http://www.lefigaro.fr/flash-actu/2011/01/04/97001-20110104FILWWW00640-un-laboratoire-attaque-prescrire.php
HSL19236
Spence D
When marketing masquerades as education
BMJ 2011 Jan 4; 342:
http://www.bmj.com/content/342/bmj.c7469.extract
HSL19152
Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK
Physician Perceptions About Generic Drugs (January)
Ann Pharmacother 2011 Jan 4;
http://www.theannals.com/cgi/content/full/45/1/31
HSL19445
There's no such thing as a free gift
The Sydney Morning Herald 2011 Jan 4
http://www.smh.com.au/opinion/editorial/theres-no-such-thing-as-a-free-gift-20110103-19dpd.html
HSL19444
Besser L
Regulator fails to keep register of drug company gifts
The Sydney Morning Herald 2011 Jan 3
http://www.smh.com.au/national/regulator-fails-to-keep-register-of-drug-company-gifts-20110102-19d2e.html
HSL19346
Rollinsa BL, Kingb K, Zinkhan G, Perri M
Nonbranded or Branded Direct-to-Consumer Prescription Drug Advertising—Which is More Effective?
Health Marketing Quarterly 2011 Jan 1; 28:(1):86 - 98
http://www.informaworld.com/smpp/content~db=all~content=a933894806
HSL19347
Kim H
Pharmaceutical Companies as a Source of Health Information: A Pilot Study of the Effects of Source, Web Site Interactivity, and Involvement
Health Marketing Quarterly 2011 Jan; 28:(1):57 - 85
http://www.informaworld.com/smpp/content~db=all~content=a933900963
HSL19012
Morelle A, Bensadon A-C, Marie E
Enquête sur le Mediator
La Documentation Francais 2011 Jan260
http://www.ladocumentationfrancaise.fr/rapports-publics/114000028/index.shtml
HSL19060
Jelinek GA, Brown AF.
A stand against drug company advertising.
Emerg Med Australas 2011; 23:(1):4-6
doi: 10.1111/j.1742-6723.2010.01393.x. No abstract available.
http://onlinelibrary.wiley.com/doi/10.1111/j.1742-6723.2010.01393.x/full
HSL19118
Gagne JJ, Choudhry NK
How Many 'Me-Too' Drugs Is Too Many?
JAMA 2011 Jan; 305:(7):711-712
http://jama.ama-assn.org/content/305/7/711.extract
HSL19157
Galizzi MM, Ghislandi S, Miraldo M
Effects of refer ence pricing in pharmaceutical markets: a review
Pharmacoeconomics 2011 Jan; 29:(1):17-33
http://www.genericsamples.com/wp/effects-of-reference-pricing-in-pharmaceutical-markets-a-review/
HSL19332
Stell LK, Stossel TP.
Another dip into the muddy waters of COI.
Am J Bioeth 2011; 11:(1):49-50
http://www.ncbi.nlm.nih.gov/pubmed/21240813
HSL19339
Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD.
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
JAMA 2011 9; 305:(10):1008-17
http://jama.ama-assn.org/content/305/10/1008.long
HSL19340
Turner EH.
The effect of funding source on outcome reporting among drug trials.
Ann Intern Med 2011 18; 154:(2):137
http://www.annals.org/content/154/2/137.1.long
HSL19344
Machado M, O'Brodovich R, Krahn M, Einarson TR
International drug price comparisons: quality assessment.
Rev Panam Salud Publica 2011; 29:(1):46-51
http://www.scielosp.org/scielo.php?pid=S1020-49892011000100007&script=sci_arttext&tlng=en
HSL19321
Money AG, Barnett J, Kuljis J, Craven MP, Martin JL, Young T
The role of the user within the medical device design and development process: medical device manufacturers' perspectives
BMC Medical Informatics and Decision Making 2011; 11:(15):
http://www.biomedcentral.com/1472-6947/11/15/abstract
HSL19327
Braillon A
Challenging Special Interest Groups: Whistleblowers May Help. Help Them!
Psychother Psychosom 2011; 80:(2):116-117
http://content.karger.com/produktedb/produkte.asp?doi=319541
HSL19066
Mason PR, Tattersall MHN
Conflicts of interest: a review of institutional policy in Australian medical schools
Med J Aust 2011; 194:(4):216
http://www.mja.com.au/public/issues/194_03_070211/mas10914_fm.html
HSL19067
Saunders C
Medical schools act on pharma influence
MJA InSight 2011; 194:(3):121-125
http://www.mjainsight.com.au/view?post=Medical+schools+act+on+pharma+influence&post_id=2938
HSL19403
Tatoulis J, Roberts LM, Mackintosh A-M
Do doctors need to exercise caution when recommending products that bear the Heart Foundation Tick? No
MJA 2011; 194:(6):285-286
http://www.mja.com.au/public/issues/194_06_210311/rob10104_fm.html
HSL19402
Stanton RA
Do doctors need to exercise caution when recommending products with the Heart Foundation Tick? Yes.
MJA 2011; 194:(6):284-285
http://www.mja.com.au/public/issues/194_06_210311/sta10096_fm.html
HSL19169
Parker MH, Wardle JL, Weir M, Stewart CL
Medical merchants: conflict of interest, office product sales and notifiable conduct
Med J Aust 2011; 194:(1):34-37
http://www.mja.com.au/public/issues/194_01_030111/par10613_fm.html
HSL19369
Steen RG.
Retractions in the scientific literature: is the incidence of research fraud increasing?
J Med Ethics 2011; 37:(4):249-53
http://jme.bmj.com/content/37/4/249.long
HSL19285
Rollins BL, King K, Zinkhan G, Perri M.
Nonbranded or Branded Direct-to-Consumer Prescription Drug Advertising-Which is More Effective?
Health Mark Q 2011; 28:(1):86-98
http://www.ncbi.nlm.nih.gov/pubmed/21347943
HSL19358
OTC Review & Outlook 2011
Pharma Live 2011
http://www.pharmalive.com/special_reports/details.cfm?reportID=336
HSL19437
Conflicts of Interest Are Prevalent Among Writers, Reviewers of Cardiovascular Clinical Practice Guidelines
Pharma Live 2011
http://pharmalive.com/news/index.cfm?articleID=770917
HSL19431
Mitka M
New 'Law' Attempts to Explain Strategies Drug Marketers Use to Sway Prescribing
JAMA 2011; 305:(11):
http://jama.ama-assn.org/content/305/11/1083.extract
HSL19399
Fugh-Berman A, Pike McDonald C, Bell AM, Bethards EC, Scialli ER
Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women's Health Initiative
PLoS Med 2011; 8:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000425
HSL19279
Rodwin MA
Conflicts of Interest and the Future of Medicine: The United States, France and Japan Oxford: Oxford University Press 20110
http://www.oup.com/us/catalog/general/subject/Politics/AmericanPolitics/PublicPolicy/~~/dmlldz11c2EmY2k9OTc4MDE5OTc1NTQ4Ng==
HSL19560
Maxwell JC.
The prescription drug epidemic in the United States: A perfect storm.
Drug Alcohol Rev 2011; 30:(3):264-70
doi: 10.1111/j.1465-3362.2011.00291.x.
http://www.ncbi.nlm.nih.gov/pubmed/21545556
HSL19602
Gharpure K, Thawani V, Sontakke S, Chaudhari K, Bankar M, Diwe R
Effect of information, education and communication intervention on awareness about rational pharmacy practice in pharmacy students
Indian J Pharmacol 2011; 43:(4): 381-384
http://www.ijp-online.com/article.asp?issn=0253-7613;year=2011;volume=43;issue=4;spage=381;epage=384;aulast=Gharpure;type=0
HSL19630
Ravi Shankar P
Understanding and responding to pharmaceutical promotion
MJA 2011; 423:(7):195
http://www.mja.com.au/public/issues/195_07_031011/sha10697_fm.html
HSL19676
Gale EAM
Conflicts of interest in guideline panel members
BMJ 2011;
HSL19677
Jack A
Letting the sunshine in on doctor-pharma relationships
BMJ 2011;
http://www.bmj.com/content/343/bmj.d6459.extract
HSL19690
Haines IE, Gabor Miklos GL
Time to mandate data release and independent audits for all clinical trials
MJA 2011; 195:(10):575-577
http://www.mja.com.au/public/issues/195_10_211111/hai10599_fm.html
HSL19691
Braillon A
Implementing US-style anti-fraud laws in the Australian pharmaceutical and health care industries
MJA 2011; 195:(10):585
http://www.mja.com.au/public/issues/195_10_211111/letters_211111_fm-9.html
HSL19692
Moynihan R
How to get full, meaningful disclosure
MJA 2011; 195:(10):571
HSL19703
Lee SS
The power of one and saving private Braillon
Liver International 2011;
braillon.net/alain/liv2723.pdf
HSL19764
Myhr K
BigPharma and unethical marketing of medicinal products
Southern Med Review 2011; 4:(2):
http://southernmedreview.org/index.php/smr/article/view/1000/20
HSL20401
Caulfield T, Rachul C
Supported by science?: What Canadian naturopaths advertise to the public
Allergy, Asthma & Clinical Immunology 2011; 7:(14):
http://www.aacijournal.com/content/7/1/14
HSL19082
Otra vez la Menopausia
No Gracias 2011
http://www.noticiascanarias.com/index2.php?option=com_content&do_pdf=1&id=41544
HSL19083
El dilema de las Guías Clínicas
No Gracias 2011
http://www.nogracias.eu/v_portal/informacion/informacionver.asp?cod=7639&te=&idage=&vap=0&codrel=642
HSL19091
Kersnik J, Klemenc-Ketis Z, Petek-Ster M, Tusek-Bunc K, Poplas-Susic T, Kolsek M.
Family doctors' views of pharmaceutical sales representatives: assessment scale development.
Fam Pract 2011 2;
http://fampra.oxfordjournals.org/content/early/2011/02/02/fampra.cmq105.long
HSL19094
Tanne JH.
'Inverse benefit law' explains how drug marketing undermines patient safety.
BMJ 2011 28; 342:d598:
doi: 10.1136/bmj.d598. No abstract available.
http://www.bmj.com/content/342/bmj.d598.long
HSL19129
Sales Through Retail Pharmacies (Twelve months to November 2010)
ims 2011 Jan
http://view.respond.imshealth.com/?j=fe54157876630d7e7c17&m=fef31377726304&ls=fdfa17757666017475127374&l=fe9615727662037d73&s=fe21127975600c75701171&jb=ffcf14&ju=fe1c1671726d0c7b771d77&r=0
HSL19401
Brody H.
Responses to peer commentaries on 'Clarifying conflict of interest'
Am J Bioeth 2011; 11:(1):W4-5
www.ncbi.nlm.nih.gov/pubmed/21240796
HSL19324
Lexchin J.
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications.
Sci Eng Ethics 2011 15;
http://www.springerlink.com/content/k3306qh046375277/
HSL19185
Vance MA.
Disease mongering and the fear of pandemic influenza.
Int J Health Serv 2011; 41:(1):95-115
http://www.ncbi.nlm.nih.gov/pubmed/21319723
HSL19186
Rusert BM, Royal CD.
Grassroots Marketing in a Global Era: More Lessons from BiDil.
J Law Med Ethics 2011; 39:(1):79-90
doi: 10.1111/j.1748-720X.2011.00552.x.
http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2011.00552.x/abstract
HSL19187
Davis C, Abraham J.
Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulation.
Sociol Health Illn 2011 11;
doi: 10.1111/j.1467-9566.2010.01310.x. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/21314687
HSL19370
Steen RG.
Retractions in the scientific literature: do authors deliberately commit research fraud?
J Med Ethics 2011; 37:(2):113-7
http://jme.bmj.com/content/37/2/113.long
HSL19631
Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL.
Pharmaceutical fraud and abuse in the United States, 1996-2010.
Arch Intern Med 2011 12; 171:(16):1503-6
http://archinte.ama-assn.org/cgi/content/full/171/16/1503
HSL19644
Corporate Voices Toolkit Ilustrates Perils of Conflicts of Interest
banthebags.org 2011 May
http://banthebags.org/347
HSL19658
Angell M
A epidemia de doença mental
Edição 59 2011
http://revistapiaui.estadao.com.br/edicao-59/questoes-medico-farmacologicas/a-epidemia-de-doenca-mental
HSL19666
Ariely D
Dan Ariely: Beware conflicts of interest
TED.com 2011 Aug
http://www.ted.com/talks/dan_ariely_beware_conflicts_of_interest.html?awesm=on.ted.com_9daV#.TmSznHlzNTQ.facebook
HSL19684
Moynihan R.
Payments to doctors in Australia are to be scrutinised after marketing tactics are exposed.
BMJ 2011 18; 343:d6714:
doi: 10.1136/bmj.d6714. No abstract available.
http://www.bmj.com/content/343/bmj.d6714.long
HSL19685
Moynihan R.
Is journalism the drug industry's new dance partner?
BMJ 2011 2; 343:d6978:
doi: 10.1136/bmj.d6978. No abstract available.
http://www.bmj.com/content/343/bmj.d6978.long
HSL19700
Australian Government
TGA reforms: A blueprint for TGA’s future
2011 Dec
http://www.tga.gov.au/pdf/media-2011-tga-reforms-111208.pdf
HSL19701
Schofferman J.
The medical-industrial complex, professional medical associations, and continuing medical education.
Pain Med 2011; 12:(12):1713-9
doi: 10.1111/j.1526-4637.2011.01282.x. Epub 2011 Dec 6.
http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2011.01282.x/abstract;jsessionid=2442C14B5DA9F2C8FEA0ACD80B235B3B.d02t02
HSL19710
Ben Goldacre: Combatendo ciência ruim
TED.com 2011 Sep0
http://www.ted.com/talks/lang/pt-br/ben_goldacre_battling_bad_science.html
Page 5 of 6 pages ‹ First < 3 4 5 6 >
